지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 저널정보
- 한국약제학회 Journal of Pharmaceutical Investigation Journal of Pharmaceutical Investigation 제52권 제6호
- 발행연도
- 2022.11
- 수록면
- 683 - 724 (42page)
- DOI
- 10.1007/s40005-022-00584-w
이용수
초록· 키워드
오류제보하기
Background Controlled release and targeted delivery of the drug payload are the two most fascinating applications of nanoparticle-based systems explored in the recent past. The advantages of achieving control over drug release kinetics include prolonged therapeutic effects, reduced dosing frequency, and fewer plasma level fluctuations and side effects, whereas targeted delivery offers enhanced drug accumulation at the site of action and reduced off-target toxicity, thereby improving the management of chronic diseases. Poly(lactic-co-glycolic acid) nanoparticles (PLGA-NPs) hold tremendous promise for such applications because of their ability to modulate drug release, pharmacokinetics, the biodistribution profiles of drugs, and the surface functionalization for targeted delivery.
Area covered This review primarily highlights the applications of PLGA-NPs based on the controlled release of therapeutics after oral, parenteral, pulmonary, ocular, intranasal, and dermal administration and tissue engineering. The potential of PLGA-NPs for targeted delivery to various diseases, such as cancer, rheumatoid arthritis, inflammatory bowel disease, and neurological disorders, has also been extensively reviewed. This review concludes with a description of the limitations of PLGA-NPs and the hurdles associated with their clinical application.
Expert opinion PLGA-NPs stand out among other nanoparticles because of their excellent biocompatibility and biodegradability.
Although the presented data suggest that they are the major shareholders in controlled-release and targeted-delivery systems, no PLGA-NP formulation has reached clinics. Therefore, further insights into the rational design of PLGA-NPs and clinically relevant testing are required to narrow the gap between the bench and bedside realities.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Lipid-based surface engineering of PLGA nanoparticles for drug and gene delivery applications
생체재료학회지
2016 .12
-
Transferrin modified PEG–PLGA nanoparticles: highly effective notoginsenoside R1 formulations for the treatment of ulcerative colitis
Journal of Pharmaceutical Investigation
2024 .05
-
Transdermal delivery of Minoxidil using HA-PLGA nanoparticles for the treatment in alopecia
생체재료학회지
2019 .01
-
Biocompatibility, biodegradation and biomedical applications of poly(lactic acid)/poly(lactic‑co‑glycolic acid) micro and nanoparticles
Journal of Pharmaceutical Investigation
2019 .01
-
Poly(lactic acid)/poly(lactic‑co‑glycolic acid) particulate carriers for pulmonary drug delivery
Journal of Pharmaceutical Investigation
2019 .01
-
PEGylated polylactide (PLA) and poly (lactic‑co‑glycolic acid) (PLGA) copolymers for the design of drug delivery systems
Journal of Pharmaceutical Investigation
2019 .01
-
Encapsulation of Low Metronidazole Dose in Poly (D,L-lactide-co-glycolide) (PLGA) Nanoparticles Improves Giardia intestinalis Treatment
Infection and Chemotherapy
2020 .01
-
Physical properties of nanoparticles do matter
Journal of Pharmaceutical Investigation
2021 .01
-
전하가 다른 PLGA 나노 입자의 생체 안정성 및 암세포에 미치는 영향
의공학회지
2018 .01
-
Poly lactic-co glycolic acid (PLGA) Nanofibrous Scaffold Chemically Coated with Gold-nanoparticles (GNPs) as Osteoinductive Agent for Osteogenesis
대한치과재료학회 학술대회
2016 .11
-
Biomimetic shear stress and nanoparticulate drug delivery
Journal of Pharmaceutical Investigation
2017 .03
-
Upregulation of Mir-34a in AGS Gastric Cancer Cells by a PLGA-PEG-PLGA Chrysin Nano Formulation
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Lamination of microfibrous PLGA fabric by electrospinning a layer of collagenhydroxyapatite composite nanofibers for bone tissue engineering
생체재료학회지
2017 .01
-
Potential of polylactic-co-glycolic acid (PLGA) for delivery Jembrana disease DNA vaccine Model (pEGFP-C1-tat)
Journal of Veterinary Science
2021 .11
-
Inhibitory effects of surface-grafted polylactide-co-glycolide nanoparticles on the pro-inflammatory polarization of macrophages
대한치과재료학회 학술대회
2022 .11
-
PLA/PLGA nanoparticles prepared by nano spray drying
Journal of Pharmaceutical Investigation
2019 .01
-
Anticancer activity of drug-loaded calcium phosphate nanocomposites against human osteosarcoma
생체재료학회지
2017 .01
-
약물 운반체로서의 폴리머 디스크 나노 입자에 대한 평가
의공학회지
2017 .01
-
The reduction of SAT1 via shRNA-encapsulated PLGA nanoparticles showed a significant alleviation of neuropathic pain
한국실험동물학회 학술발표대회 논문집
2022 .01
-
약물지연방출을 위한 스테레오컴플렉스 PLA 원반형 마이크로입자
의공학회지
2020 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0